Clene Inc. (CLNNW)
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
Broadcom Inc. to Announce Second Quarter Fiscal Year 2026 Financial Results on Wednesday, June 3, 2026
Easterly Government Properties to Participate in Wells Fargo 29th Annual Real Estate Securities Conference
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis
More Than 4.4 Million Guests at AMC Theatres and ODEON Cinemas Affirm That Big Opening Weekends Are Staying in Fashion in 2026, as THE DEVIL WEARS PRADA 2 Scores a Reported $233 Million Worldwide to Kick off the “Summer Moviegoing Season”
OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)
Genius Sports and Liga MX Strike Landmark Technology and AI Partnership to Drive Future of Mexican Soccer
JLens Urges Meta Shareholders to Vote FOR Proposal 8 at the Company’s Annual Meeting on May 27, 2026
Wheels Up Announces Date of First Quarter 2026 Earnings Release
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
Toast Announces New Alliance Partnership With Preferred Hotels & Resorts, The World’s Largest Independent Hotel Brand
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations